Simplex Trading’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Simplex Trading’s Portfolio ODT Stock Details ODT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,000	Closed	-$2K	–	11748
2022 Q1	$2K	Sell	2,000 -6,982	-78%	-$8.76K	﹤0.01%	10010
2021 Q4	$12K	Sell	8,982 -1,429	-14%	-$3.38K	﹤0.01%	8912
2021 Q3	$35K	Hold	10,411	–	–	﹤0.01%	7963
2021 Q2	$36K	Sell	10,411 -48,698	-82%	-$167K	﹤0.01%	8062
2021 Q1	$202K	Buy	+59,109	New	+$1.12M	﹤0.01%	4729
2020 Q4	–	Sell	-8,087	Closed	-$125K	–	9389
2020 Q3	$108K	Buy	8,087 +7,987	+7,987%	+$226K	﹤0.01%	4824
2020 Q2	$4K	Buy	+100	New	+$3.24K	﹤0.01%	7103

Simplex Trading's ODT Position: Q2 2022 in Review

Simplex Trading sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q2 2022, closing a stake of 2,000 shares — an estimated $2K sold.

Simplex Trading first reported a position in ODT in Q2 2020 and held it in 7 quarters. The position peaked at $202K in Q1 2021. 0 funds tracked by Wall St. Rank hold ODT as of Q2 2022.

Simplex Trading reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Simplex Trading sold 2,000 Odonate Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $2K.
Simplex Trading first reported a position in Odonate Therapeutics, Inc. Common Stock in Q2 2020 and held it in 7 quarters.
Simplex Trading's Odonate Therapeutics, Inc. Common Stock position peaked at $202K in Q1 2021.
0 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Simplex Trading's 13F filing for Q2 2022, filed 3 Aug 2022.